Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for CDNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 51.48M
March 31, 2026 51.27M
December 31, 2025 50.92M
September 30, 2025 51.41M
June 30, 2025 53.22M
March 31, 2025 55.46M
December 31, 2024 54.77M
September 30, 2024 53.11M
June 30, 2024 52.62M
March 31, 2024 51.78M
December 31, 2023 51.50M
September 30, 2023 54.15M
June 30, 2023 54.01M
March 31, 2023 53.65M
December 31, 2022 53.53M
September 30, 2022 53.52M
June 30, 2022 53.32M
March 31, 2022 53.09M
December 31, 2021 52.92M
September 30, 2021 52.78M
June 30, 2021 52.55M
March 31, 2021 51.94M
December 31, 2020 49.44M
September 30, 2020 49.13M
June 30, 2020 48.86M
Date Value
March 31, 2020 43.02M
December 31, 2019 42.50M
September 30, 2019 42.42M
June 30, 2019 42.31M
March 31, 2019 41.91M
December 31, 2018 41.38M
September 30, 2018 38.78M
June 30, 2018 35.98M
March 31, 2018 35.24M
December 31, 2017 28.82M
September 30, 2017 22.56M
June 30, 2017 21.42M
March 31, 2017 21.36M
December 31, 2016 21.28M
September 30, 2016 21.23M
June 30, 2016 18.93M
March 31, 2016 11.98M
December 31, 2015 11.90M
September 30, 2015 11.89M
June 30, 2015 11.84M
March 31, 2015 11.82M
December 31, 2014 11.80M
September 30, 2014 11.79M
June 30, 2014 12.17M
March 31, 2014 6.936M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Natera, Inc. 143.61M
Caris Life Sciences, Inc. 282.58M
Myriad Genetics, Inc. 95.60M
BioRestorative Therapies, Inc. 1.274M
Exagen, Inc. 24.19M